Welcome to our dedicated page for VERANO HLDGS news (Ticker: VRNO), a resource for investors and traders seeking the latest updates and insights on VERANO HLDGS stock.
Verano Holdings Corp. (VRNO) is a vertically integrated, multi-state cannabis company whose activities generate frequent news across operations, finance, regulation and product development. As one of the U.S. cannabis industry’s notable operators by historical revenue, geographic scope and brand performance, Verano’s announcements often reflect broader developments in regulated cannabis markets.
News about Verano commonly covers its expanding retail and cultivation footprint, including new Zen Leaf™ and MÜV™ dispensary openings and updates on its 13-state operations. Articles may highlight additional dispensary locations in medical markets such as West Virginia, or progress on licenses like the conditional Dispensing Organization License in Texas, which, subject to final approval, would permit cultivation, processing and dispensing of medical cannabis in that state.
Investors and industry followers can also expect coverage of Verano’s branded product portfolio. This includes launches and expansions of brands such as Swift Lifts, a pre-roll brand positioned around quality and convenience, as well as updates on products sold under the Verano™, (the) Essence™, MÜV™, Savvy™, BITS™, Encore™, and Avexia™ labels.
Financial and regulatory news is another key theme, including disclosures on credit facilities and capital structure. For example, Verano has reported amendments to its revolving credit facility that increased borrowing capacity and extended maturity, as well as commentary on federal policy shifts like cannabis rescheduling initiatives. For readers tracking VRNO, this news feed offers a centralized view of the company’s operational milestones, financing developments and regulatory context over time.
Verano (VRNO) will participate in the ATB Cormark Cannabis Institutional Investor Conference 2026 on September 9, 2026, in New York City. Members of the executive leadership team plan to attend and hold investor meetings during the event.
Verano (Cboe CA: VRNO, OTCQX: VRNO) launched Easy Landings, its first dedicated cannabis beverage brand, featuring 100 mg single-serve, 2 oz fast-acting THC shots in four flavors: Lemon Lime, Watermelon, Mango and Black Cherry. Each capful provides 5 mg THC for simple dose control.
Easy Landings debuts August 21, 2026 at Verano’s Zen Leaf dispensaries and third-party partners in Arizona, Illinois and Nevada, followed by New Jersey on August 28, with plans to expand to additional states. According to Verano, the brand targets rising demand for THC beverages and macrodose edibles, noting 2025 cannabis beverage dispensary sales grew 13% across its operating markets.
Verano (Cboe CA: VRNO, OTCQX: VRNO) announced that its executive leadership will participate in the Canaccord Genuity 46th Annual Growth Conference on August 11, 2026 in Boston, MA. Management will join a fireside chat and investor meetings at 10:30 a.m. ET, accessible via an online webcast link provided by the company.
Verano (Cboe CA/OTCQX: VRNO) reported second quarter 2026 revenue of $218 million, up 5% sequentially and 8% year-over-year, delivering its third consecutive quarter of revenue growth. Gross profit was $100 million, representing a 46% margin, with SG&A of $92 million, or 42% of revenue.
The company posted a net loss of $13 million, or -6% margin, and Adjusted EBITDA of $51 million, or 24% margin. Operating cash flow was $31 million, up from $11 million a year earlier, and capital expenditures were $12 million/b. Verano tightened 2026 capex guidance to
Verano (Cboe CA/OTCQX: VRNO) announced the grand opening of MÜV Bradfordville in the Tallahassee area on Friday, July 17, 2026, raising its Florida footprint to 86 MÜV dispensaries and 163 locations nationwide. The store at 6808 Thomasville Rd will operate seven days a week with extended hours.
MÜV Bradfordville is Verano’s second dispensary in Leon County, complementing MÜV Tallahassee and serving a metro area of more than 300,000 residents. According to Verano, patients gain access to its branded flower, edibles, concentrates, the HYPHEN vape system, Avexia topicals, Savvy pre-rolls, and exclusive Flower by Edie Parker products.
Verano (Cboe CA: VRNO, OTCQX: VRNOD) will release its second quarter 2026 financial results before market open on August 5, 2026. A conference call and live webcast with analysts and investors will be held that day at 8:30 a.m. ET.
The webcast and replay will be accessible via the investor relations site. Verano’s common stock is temporarily trading under VRNOD, expected to revert to VRNO on or around July 9, 2026.
Verano (Cboe CA: VRNO, OTCQX: VRNO) completed a 1-for-5 reverse stock split of its common stock effective June 11, 2026, and reduced authorized shares from 5,000,000,000 to 1,000,000,000.
Issued shares fell from 367,690,781 to about 73,918,135, supporting efforts toward a prospective U.S. exchange listing.
Verano (VRNO) approved a 1-for-5 reverse stock split of its common stock, expected to take effect on or about June 11, 2026. The move aims to support a prospective U.S. stock exchange listing, reduce outstanding shares from about 364.4M to 72.9M, and is expected to raise the per-share price.
Verano (Cboe CA: VRNO, OTCQX: VRNO) is celebrating Zen Leaf’s 10-year Las Vegas anniversary with “All-in-at-10” events from May 21-30 across its Flamingo, Fort Apache and North Las Vegas dispensaries.
The 10-day campaign features rotating daily discounts, Elvis lookalike contests, small business tie-ins and donations from a portion of daily proceeds to 10 local non-profits. Guests can collect stamps in a limited “All-in-at-10 Playbook” to unlock added perks, including chances to win free cannabis for a year and an invite-only June event.
According to Verano, it operates 162 dispensaries and 14 cultivation and processing facilities across 13 U.S. states, with over 1.1 million square feet of cultivation capacity.
Verano (VRNO) announced it has submitted DEA registration applications for certain state-licensed medical cannabis businesses, using the expedited pathway created by federal rescheduling of medical marijuana to Schedule III. The company operates in 13 U.S. states with 162 dispensaries and 14 production facilities totaling over 1.1 million square feet of cultivation capacity.